These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27612807)

  • 21. Efficient Delivery of Lomitapide using Hybrid Membrane-Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy.
    Song M; Tian J; Wang L; Dong S; Fu K; Chen S; Liu C
    Adv Mater; 2024 Jun; 36(24):e2311760. PubMed ID: 38569065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model.
    Dilnawaz F; Sahoo SK
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):452-62. PubMed ID: 23891772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
    Ung TH; Malone H; Canoll P; Bruce JN
    CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
    Li AJ; Zheng YH; Liu GD; Liu WS; Cao PC; Bu ZF
    Mol Med Rep; 2015 Apr; 11(4):3078-86. PubMed ID: 25434368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
    Agarwal S; Muniyandi P; Maekawa T; Kumar DS
    Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells.
    Martinkova E; Maglott A; Leger DY; Bonnet D; Stiborova M; Takeda K; Martin S; Dontenwill M
    Int J Cancer; 2010 Sep; 127(5):1240-8. PubMed ID: 20099278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs.
    Kim C; Shah BP; Subramaniam P; Lee KB
    Mol Pharm; 2011 Oct; 8(5):1955-61. PubMed ID: 21793576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of ultra-small lipid nanoparticle surface charge for targeting glioblastoma.
    Mendes M; Miranda A; Cova T; Gonçalves L; Almeida AJ; Sousa JJ; do Vale MLC; Marques EF; Pais A; Vitorino C
    Eur J Pharm Sci; 2018 May; 117():255-269. PubMed ID: 29486328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioengineering fluorescent virus-like particle/RNAi nanocomplexes act synergistically with temozolomide to eradicate brain tumors.
    Pang HH; Huang CY; Chou YW; Lin CJ; Zhou ZL; Shiue YL; Wei KC; Yang HW
    Nanoscale; 2019 Apr; 11(17):8102-8109. PubMed ID: 30982841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temozolomide nanoparticles for targeted glioblastoma therapy.
    Fang C; Wang K; Stephen ZR; Mu Q; Kievit FM; Chiu DT; Press OW; Zhang M
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6674-82. PubMed ID: 25751368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes.
    Tseng YY; Huang YC; Yang TC; Yang ST; Liu SC; Chang TM; Kau YC; Liu SJ
    Sci Rep; 2016 Jul; 6():30630. PubMed ID: 27471070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma.
    Majumder P; Baxa U; Walsh STR; Schneider JP
    Angew Chem Int Ed Engl; 2018 Nov; 57(46):15040-15044. PubMed ID: 30240496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy].
    Chen WG; Wang SB
    Yao Xue Xue Bao; 2013 Jul; 48(7):1091-8. PubMed ID: 24133974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
    Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
    Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.